Microbiology of the Burn Compromised Patient

  • Ian Alan Holder


The kinds of microorganisms isolated from the wounds of burn patients from 1964–1988 are presented and their association with infections and septic deaths in this patient population is reviewed. Procedures for testing of antimicrobial creams and solutions for topical use in burn wound care are presented and data resulting from these types of assays are discussed. A brief discussion of the pros and cons of quantitative microbial wound culture is presented as well.


Pseudomonas Aeruginosa Candida Tropicalis Burned Patient Wound Sepsis Silver Sulfadiazine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alford RH, Hall A. Epidemiology of infections caused by gentamincin-resistant enterobacteriaceae and Pseudomonasaeruginosa over 15 years at the Nashville Veterans Administration Medical Center. Rev Infect Dis 9: 1079–1086, 1987.CrossRefGoogle Scholar
  2. 2.
    Arnow PM, Allyn PA, Nichols, M, Hill DI, Pezzlo M, Bartlett PH. Control of methicillin-resistant Staphylococcus aureus in a burn unit: role of nurse staffing. J Trauma 22: 954–959, 1982.CrossRefGoogle Scholar
  3. 3.
    Ayliffe GAJ, Green W, Livingston R. Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards. J Clin Path 30: 40–44, 1977.CrossRefGoogle Scholar
  4. 4.
    Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of Methidllin-resistant Staphylococcus aureus infections. JAMA 249: 2803–2807, 1983.CrossRefGoogle Scholar
  5. 5.
    Bruck HM, Nash G, Pruitt BS, Jr. Opportunistic fungal infection of the burn wound with phycomycetes and Aspergillus. Arch Surg 102: 476–481, 1972.Google Scholar
  6. 6.
    Cason KS, Lowbury EJ. Mortality and infection in extensively burned patients treated with silver nitrate compresses. Lancet 1: 651, 1968.CrossRefGoogle Scholar
  7. 7.
    Cruickshank R. The bacterial infection of burns. J Path 41: 367, 1935.CrossRefGoogle Scholar
  8. 8.
    Everett, ED, McNitt TR, Rahm AE. Epidemiologic investigation of methicillin-resistant Staphylococcus aure-us in a burn unit. Milit Med 143: 165–167, 1978.Google Scholar
  9. 9.
    Heggers JP, Velanovich V, Robson MC, Zoellner SM, Schileru R, Boertman J, Xing-Tao N. Control of burn wound sepsis: a comparison of in vitro topical antimicrobial assays. J Trauma 27: 176–179, 1987.CrossRefGoogle Scholar
  10. 10.
    Henjyoji EY. Bacteremia due to Serratia marcescens. J Trauma 11: 417–419, 1971.CrossRefGoogle Scholar
  11. 11.
    Holder IA. Gentamidn resistant Pseudomonasaeruginosa in a burns unit. J Antimicrob Chemother 2: 309–316, 1976.CrossRefGoogle Scholar
  12. 12.
    Holder IA. The pathogenesis of infections owing to Pseudomonasaeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati. Can J Microbiol 31: 393–402, 1985.CrossRefGoogle Scholar
  13. 13.
    Holder IA. The wet disc antimicrobial solution assay: an invitro method to test efficacy of antimicrobial solutions for topical use. J Burn Care Rehab 10: 203–208, 1989.CrossRefGoogle Scholar
  14. 14.
    Holder IA, Schwab M, Jackson L. Eighteen months of routine topical; antimicrobial susceptibility testing of isolates from burnpatients: results and conclusions. J An timicrob Chemother 5: 455–463, 1979.CrossRefGoogle Scholar
  15. 15.
    Kagan RJ, Naraqi S, Matsuda T, Jonasson OM. Herpes simplex virus and cytomegalovirus infections in burned patients. J Trauma 25: 40–45, 1985.CrossRefGoogle Scholar
  16. 16.
    Kim HS, Hubbard GB, Worley BL, McManus WF, Mason AD, Pruitt BA. A rapid section technique for burn wound biopsy. J Burn Care Rehab 6: 433–435, 1985.CrossRefGoogle Scholar
  17. 17.
    Langhor J, Owen C, Cope O. Bacteriologic study of burn wounds. Ann Surg 125: 452–457, 1947.CrossRefGoogle Scholar
  18. 18.
    Law EJ, Holder IA, McMillan BG. Candida parapsilosis fungemia in burn patients: report of three cases. Burns: 10: 203–206, 1983.CrossRefGoogle Scholar
  19. 19.
    LeFrock JL, Molavi A, Smith BR. Current use of aminoglycosides. Infect Surg 3: 57–65, 1984.Google Scholar
  20. 20.
    Levine MS, Lindberg RB, Mason AD. The quantitative swab culture and smear: a quick simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma 16: 89–94, 1976.CrossRefGoogle Scholar
  21. 21.
    Linnemann CC, MacMillan BG. Viral infections in pediatric burn patients. Am J Dis Child 135: 750–753, 1981.Google Scholar
  22. 22.
    Loebl EC, Marvin JA, Heck EL. The method of quantitative burn-wound biopsy cultures and its routine use in the care of the burned patient. Am J Clin Path 61: 20–24, 1974.Google Scholar
  23. 23.
    Lorenti AS, Carbonell-Bensadon JM, Benaim F. Sensibility assay for topical agents. J Burn Care Rehab 10: 209–212, 1989.CrossRefGoogle Scholar
  24. 24.
    Lynch JB, et al. Changing patterns of mortality in burns. Plast Reconstr Surg 48: 329–332, 1971.CrossRefGoogle Scholar
  25. 25.
    MacMillan BG. Ecology of bacteria colonizing the burned patient given topical and systemic gentamidn therapy: A five-year study. J Infect Dis 124: 5278–5286, 1971CrossRefGoogle Scholar
  26. 26.
    Maley MP. Methidllin-resistant Staphylococcus aureus. Lancet 605, 1985.Google Scholar
  27. 27.
    Mangus DJ, Fox D, Gilchrist D, Womack B, Ost J. Quantitative evaluation and laboratory studies of topical antibiotic therapy in burns. J Burn Care Rehab 6: 39–46, 1985.CrossRefGoogle Scholar
  28. 28.
    Mayhall CG, Polk RE, Haynes BW. Infections in burned patients. Infect Control 4: 454–459, 1983.Google Scholar
  29. 29.
    Mitchell V, Galizia JP, Fournier L. Precise diagnosis of infection in burn wound biopsy specimens. J Burn Care Rehab 10: 195–202, 1999.CrossRefGoogle Scholar
  30. 30.
    Modak SM, Fox CL. Sulfadiazine silver-resistant Pseudomonas in burns. Arch Surg 116: 854–857, 1981.CrossRefGoogle Scholar
  31. 31.
    Moyer CA, Brentano L, Cravens DL, Margraf HW, Monafo WW. Treatment of large human burns with 0.5 percent silver nitrate solution. Arch Surg 90: 812–867, 1965.CrossRefGoogle Scholar
  32. 32.
    Murphy RC, Kucan JO, Robson MC, Heggers JP. The effect of 5 percent Mafenide acetate solution of bacterial control in infected rat burns. J Trauma 23: 878–881, 1983.CrossRefGoogle Scholar
  33. 33.
    Nathan P, Holder IA, MacMillan B. Burn wounds: Microbiology, local host defenses and current therapy. Crit Rev Clin Lab Sci 4: 61–100, 1973.CrossRefGoogle Scholar
  34. 34.
    Nathan P, Law EJ, Murphy DF, MacMillan BG. A laboratory method for selection of topical antimicrobial agents to treat infected burn wounds. Burns 4: 177–187, 1978.CrossRefGoogle Scholar
  35. 35.
    Neal GD, Lindholm GF, Lee MJ. Burn wound histologic culture: a new technique for predicting burn wound sepsis. J Bum Care Rehab 2: 35–39, 1981.CrossRefGoogle Scholar
  36. 36.
    Pruitt BA. Treating burn and soft tissue infections. Infect Surg 2: 625–650, 1983.Google Scholar
  37. 37.
    Rodheaver GT, Gentry S, Saffer L, Edlich RF. Topical antimicrobial cream sensitivity testing. Surg Gynecol Obstet 151: 747–752, 1980.Google Scholar
  38. 38.
    Saymen DG, Nathan P, Holder IA, Hill EO, MacMillan BG. Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. Appl Microbiol 23: 509–514, 1972.Google Scholar
  39. 39.
    Shuck JM, Einfeldt LE, Trainor MP. Sulfamylon solution dressings in the management of burn wounds: preliminary clinical report. J Trauma 12: 999–1002, 1972.CrossRefGoogle Scholar
  40. 40.
    Spebar MJ, Walters MI, Pruitt BA, Jr. Improved survival with aggressive surgical management of noncandidal fungal infections of the burn wound. J Trauma 33: 867–868, 1982.CrossRefGoogle Scholar
  41. 41.
    Speller DCE, Raghunath D, Stephens M. Epidemic infection by a gentamicin-resistant Staphylococcus aureua in three hospitals. Lancet 1: 464–466, 1976.CrossRefGoogle Scholar
  42. 42.
    Stieritz D, Law E, Holder IA. Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients. J Clin Path 26: 405, 1973.CrossRefGoogle Scholar
  43. 43.
    Teplitz C, Davis D, Mason AD Jr. Pseudomonas burn wound sepsis. I. Pathogenesis of experimental pseudomonas burn wound sepsis. J Surg Res 1: 200–216, 1964.CrossRefGoogle Scholar
  44. 44.
    Waisbren BA. Treatment of severe burns. Comp Therapy 2: 33–42, 1976.Google Scholar
  45. 45.
    Wickman K. Studies on burns. XIV. Bacteriology. II. Acta Chir Scand suppl 408: 1–34, 1970.Google Scholar
  46. 46.
    Woolfrey BF, Fox JM, Quail CD. An evaluation of burn wound quantitative microbiology. I. Quantitative es-char cultures. Am J Clin Path 75: 532–537, 1981.Google Scholar
  47. 47.
    Woolfrey BF, Fox JMK, Quall CO. An evaluation of burn wound microbiology: the quantitative gram stain. J Burn Care Rehab 3: 171–175, 1982.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1990

Authors and Affiliations

  • Ian Alan Holder

There are no affiliations available

Personalised recommendations